semaglutide weight loss liver transplant recipients The Impact of Metabolic Health and Obesity on Candidates and The Food and Drug Administration

Bkdal TA, Thomsen M, Kupov V, Hansen CW, Anderson TW

Jan 1 2012;52(1):182-190

Treat 12, 817822

It says that if severe or persistent side effects continue beyond week 4, or if weight loss plateaus after 12 weeks despite compliance, the provider may recommend an adjustment, an alternative compounded formulation, or evaluation of combination therapy

As of May 31, 2026 the agency reported 990 adverse event reports associated with compounded semaglutide and more than 730 associated with compounded tirzepatide, and noted these are likely underreported

You can also inquire about the consultation processdo they discuss your symptoms and goals beforehand